Dar Al-Shifa Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Dar Al-Shifa Pharmaceuticals has a total shareholder equity of $27.3M and total debt of $20.2M, which brings its debt-to-equity ratio to 74%. Its total assets and total liabilities are $72.3M and $45.0M respectively. Dar Al-Shifa Pharmaceuticals's EBIT is $6.9M making its interest coverage ratio 5.4. It has cash and short-term investments of $948.3K.
Key information
74.0%
Debt to equity ratio
US$20.17m
Debt
Interest coverage ratio | 5.4x |
Cash | US$948.33k |
Equity | US$27.27m |
Total liabilities | US$45.04m |
Total assets | US$72.32m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PHARMACARE's short term assets ($29.7M) exceed its short term liabilities ($21.2M).
Long Term Liabilities: PHARMACARE's short term assets ($29.7M) exceed its long term liabilities ($23.9M).
Debt to Equity History and Analysis
Debt Level: PHARMACARE's net debt to equity ratio (70.5%) is considered high.
Reducing Debt: PHARMACARE's debt to equity ratio has increased from 58.1% to 74% over the past 5 years.
Debt Coverage: PHARMACARE's debt is well covered by operating cash flow (41.8%).
Interest Coverage: PHARMACARE's interest payments on its debt are well covered by EBIT (5.4x coverage).